Press Releases BioPorto A/S

Equities

Delayed Nasdaq Copenhagen Other stock markets 03:18:35 2024-05-03 am EDT			5-day change	1st Jan Change
1.304 ^DKK	+0.62%		+6.02%	-37.61%

Apr. 10	BioPorto Names New Chief Legal Officer	MT
Apr. 10	Bioporto A/S Appoints Gry Louise Husby Larsen as Chief Legal Officer and Member of the Executive Management Team, Effective as of April 15, 2024	CI

Resolutions of Annual Geneal Meeting	Apr. 30	GL
Grant of warrants	Apr. 23	GL
BioPorto A/S Appoints Chief Legal Officer	Apr. 10	GL
New Board Candidate for the upcoming Annual Geneal Meeting	Apr. 05	GL
Notice convening the Annual General Meeting in BioPorto A/S	Apr. 04	GL
Correction: BioPorto Announces Annual Results for 2023	Apr. 04	GL
BioPorto Announces Annual Results for 2023	Apr. 04	AQ
BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer	Apr. 02	GL
BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026	Feb. 22	GL
Roche Diagnostics and BioPorto expand collaboration	Feb. 20	GL
BioPorto implements changes to the Executive Management.	Jan. 09	GL
Managers’ transactions	Dec. 09	AQ
Managers’ transactions	Dec. 09	GL
BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United States First Test to Aid in Assessing AKI Risk for Patients Aged 3 Months Through 21 Years	Dec. 07	GL
Resignation of Director	Dec. 04	GL
BioPorto Announces Interim Results and Business Update For the Third Quarter and Nine Months of Fiscal 2023	Nov. 01	GL
BioPorto provides interim Q3 results and revised 2023 Financial Guidance.	23-10-31	GL
BioPorto provides interim Q3 results and revised 2023 Financial Guidance.	23-10-31	AQ
Grant of Warrants	23-09-22	GL
BioPorto Initiates Search for new CFO as Neil Goldman Resigns	23-09-19	GL

No results for this search